Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTransplantation, HomologousMultiple MyelomaTreatment OutcomeTransplantation ConditioningMelphalanCyclophosphamideBone Marrow TransplantationSalvage TherapyStem CellsLymphoma, Non-HodgkinRemission InductionDisease-Free SurvivalEtoposideAntineoplastic AgentsHodgkin DiseaseHematopoietic Stem Cell MobilizationRecurrenceCarmustineCell TransplantationCytarabineSurvival RateMyeloablative AgonistsLiver TransplantationGraft vs Host DiseaseBone Marrow PurgingSurvival AnalysisEmbryonic Stem CellsHematologic NeoplasmsGraft SurvivalWhole-Body IrradiationVincristineThiotepaDoxorubicinHematopoietic Stem CellsRetrospective StudiesCell DifferentiationChemotherapy, AdjuvantBusulfanPrognosisAntigens, CD34Induced Pluripotent Stem CellsFollow-Up StudiesDexamethasoneKidney TransplantationGranulocyte Colony-Stimulating FactorAntineoplastic Agents, AlkylatingLymphoma, Mantle-CellLeukapheresisTime FactorsAmyloidosisAntibodies, Monoclonal, Murine-DerivedThalidomideBoronic AcidsPyrazinesPluripotent Stem CellsLymphomaIfosfamideLymphoma, FollicularPrednisoneInduction ChemotherapyAutograftsNeoplasm, ResidualTransplantation ChimeraMesenchymal Stem Cell TransplantationLymphoma, T-Cell, PeripheralTissue DonorsCell Culture TechniquesCells, CulturedCell SeparationLeukemia, Myeloid, AcuteHeart TransplantationCord Blood Stem Cell TransplantationCisplatinPodophyllotoxinImmunosuppressive AgentsIdarubicinLymphoma, Large B-Cell, DiffuseMaintenance ChemotherapyLung TransplantationDose-Response Relationship, DrugMyelodysplastic SyndromesProspective StudiesBlood Component RemovalFeasibility StudiesNeoplasm Recurrence, LocalDrug Administration ScheduleAntibodies, MonoclonalCarboplatinBone MarrowMitoxantroneCell LineageLymphoma, B-CellHistocompatibility TestingOrgan Transplantation